Pain management and the opioid epidemic : balancing societal and individual benefits and risks of prescription opioid use

Pain management and the opioid epidemic balancing societal and individual benefits and risks of prescription opioid use

Mostrar otras versiones (1)

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the risi...

Descripción completa

Detalles Bibliográficos
Autor principal: National Academies of Sciences, Engineering, and Medicine.
Autor Corporativo: National Academies of Sciences, Engineering, and Medicine. Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse (-)
Otros Autores: Bonnie, Richard J., editor (editor), Ford, Morgan A., editor, Phillips, Jonathan (Public health researcher), editor
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, DC : The National Academies Press [2017]
Colección:National Academies ebooks.
Acceso en línea:Conectar con la versión electrónica
Ver en Universidad de Navarra:https://innopac.unav.es/record=b44944780*spi
Descripción
Sumario:Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Descripción Física:1 recurso electrónico ([393] páginas) : ilustraciones
Formato:Forma de acceso: World Wide Web.
Bibliografía:Incluye referencias bibliográficas.
ISBN:9780309462686
9780309459556

Ejemplares similares